Trade Dyadic International, Inc. - DYAI CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
| Spread | 0.1328 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.024068% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.001846% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 20% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Key Stats
| Prev. Close* | 1.2746 |
| Open* | 1.2931 |
| 1-Year Change* | -60.21% |
| Day's Range* | 1.2836 - 1.3229 |
| 52 wk Range | 1.12-3.56 |
| Average Volume (10 days) | 41.43K |
| Average Volume (3 months) | 693.48K |
| Market Cap | 37.99M |
| P/E Ratio | -100.00K |
| Shares Outstanding | 28.56M |
| Revenue | 2.50M |
| EPS | -0.42 |
| Dividend (Yield %) | N/A |
| Beta | 0.65 |
| Next Earnings Date | Mar 29, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 21, 2023 | 1.3036 | 0.0105 | 0.81% | 1.2931 | 1.3229 | 1.2836 |
| Mar 20, 2023 | 1.2746 | 0.0769 | 6.42% | 1.1977 | 1.2938 | 1.1973 |
| Mar 17, 2023 | 1.1885 | -0.1149 | -8.82% | 1.3034 | 1.3034 | 1.1785 |
| Mar 16, 2023 | 1.2936 | -0.0473 | -3.53% | 1.3409 | 1.3417 | 1.2164 |
| Mar 15, 2023 | 1.3319 | -0.0188 | -1.39% | 1.3507 | 1.3899 | 1.3217 |
| Mar 14, 2023 | 1.4092 | -0.1718 | -10.87% | 1.5810 | 1.6010 | 1.4080 |
| Mar 13, 2023 | 1.5812 | 0.2211 | 16.26% | 1.3601 | 1.6106 | 1.3601 |
| Mar 10, 2023 | 1.4374 | -0.0867 | -5.69% | 1.5241 | 1.5914 | 1.4178 |
| Mar 9, 2023 | 1.5431 | -0.1146 | -6.91% | 1.6577 | 1.6777 | 1.5233 |
| Mar 8, 2023 | 1.6390 | 0.0192 | 1.19% | 1.6198 | 1.6392 | 1.5229 |
| Mar 7, 2023 | 1.5421 | 0.2106 | 15.82% | 1.3315 | 1.6202 | 1.3315 |
| Mar 6, 2023 | 1.3323 | -0.1047 | -7.29% | 1.4370 | 1.4378 | 1.3029 |
| Mar 3, 2023 | 1.3994 | 0.0585 | 4.36% | 1.3409 | 1.3997 | 1.3409 |
| Mar 2, 2023 | 1.3417 | -0.0859 | -6.02% | 1.4276 | 1.4378 | 1.3315 |
| Mar 1, 2023 | 1.4378 | 0.0969 | 7.23% | 1.3409 | 1.4378 | 1.3409 |
| Feb 28, 2023 | 1.3129 | 0.1148 | 9.58% | 1.1981 | 1.3134 | 1.1883 |
| Feb 27, 2023 | 1.1885 | -0.0002 | -0.02% | 1.1887 | 1.1983 | 1.1307 |
| Feb 24, 2023 | 1.1881 | -0.0194 | -1.61% | 1.2075 | 1.2271 | 1.1881 |
| Feb 23, 2023 | 1.2364 | -0.0672 | -5.15% | 1.3036 | 1.3036 | 1.2071 |
| Feb 22, 2023 | 1.2846 | -0.0761 | -5.59% | 1.3607 | 1.3805 | 1.2650 |
Dyadic International, Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Annual
- Quarterly
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Total revenue | 2.40383 | 1.60192 | 1.68108 | 1.29545 | 0.75842 |
| Revenue | 2.40383 | 1.60192 | 1.68108 | 1.29545 | 0.75842 |
| Cost of Revenue, Total | 1.94444 | 1.42493 | 1.4597 | 1.02728 | 0.6802 |
| Gross Profit | 0.45939 | 0.17699 | 0.22138 | 0.26817 | 0.07822 |
| Total Operating Expense | 17.1313 | 11.6276 | 10.9637 | 8.8879 | 3.52708 |
| Selling/General/Admin. Expenses, Total | 6.69762 | 6.0848 | 5.51992 | 4.52268 | 5.03035 |
| Research & Development | 8.39237 | 3.86812 | 3.95632 | 3.31716 | 2.2031 |
| Interest Expense (Income) - Net Operating | 0.09689 | 0.06235 | 0.02773 | 0.02078 | -0.24906 |
| Unusual Expense (Income) | 0 | -4.35822 | |||
| Other Operating Expenses, Total | 0 | 0.18739 | 0 | 0.22072 | |
| Operating Income | -14.7275 | -10.0257 | -9.28259 | -7.59245 | -2.76866 |
| Interest Income (Expense), Net Non-Operating | 1.65724 | 0.73171 | 0.98493 | 0.89453 | 0.56615 |
| Net Income Before Taxes | -13.0702 | -9.29396 | -8.29766 | -6.69791 | -2.20251 |
| Net Income After Taxes | -13.0702 | -9.32527 | -8.30797 | -5.69176 | -1.33582 |
| Net Income Before Extra. Items | -13.0702 | -9.32527 | -8.30797 | -5.69176 | -1.33582 |
| Total Extraordinary Items | -0.8 | ||||
| Net Income | -13.0702 | -9.32527 | -8.30797 | -5.69176 | -2.13582 |
| Income Available to Common Excl. Extra. Items | -13.0702 | -9.32527 | -8.30797 | -5.69176 | -1.33582 |
| Income Available to Common Incl. Extra. Items | -13.0702 | -9.32527 | -8.30797 | -5.69176 | -2.13582 |
| Diluted Net Income | -13.0702 | -9.32527 | -8.30797 | -5.69176 | -2.13582 |
| Diluted Weighted Average Shares | 27.8381 | 27.4716 | 27.0037 | 27.6733 | 28.918 |
| Diluted EPS Excluding Extraordinary Items | -0.46951 | -0.33945 | -0.30766 | -0.20568 | -0.04619 |
| Diluted Normalized EPS | -0.46951 | -0.33945 | -0.30766 | -0.20568 | -0.14415 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Total revenue | 0.64843 | 0.31329 | 0.69293 | 0.93709 | 0.46052 |
| Revenue | 0.64843 | 0.31329 | 0.69293 | 0.93709 | 0.46052 |
| Cost of Revenue, Total | 0.40475 | 0.33163 | 0.39254 | 0.8295 | 0.39076 |
| Gross Profit | 0.24368 | -0.01834 | 0.30039 | 0.10759 | 0.06976 |
| Total Operating Expense | 3.39306 | 4.52908 | 4.01693 | 4.80417 | 3.78114 |
| Selling/General/Admin. Expenses, Total | 1.6557 | 1.70316 | 1.69284 | 1.74761 | 1.55401 |
| Research & Development | 1.34286 | 2.47348 | 1.90155 | 2.20924 | 1.8081 |
| Interest Expense (Income) - Net Operating | -0.01025 | 0.02081 | 0.03 | 0.01781 | 0.02827 |
| Operating Income | -2.74463 | -4.21579 | -3.324 | -3.86708 | -3.32062 |
| Interest Income (Expense), Net Non-Operating | 0.00297 | 1.60746 | 0.0032 | 0.0209 | 0.02567 |
| Net Income Before Taxes | -2.49167 | -4.21386 | -1.71527 | -3.84617 | -3.29495 |
| Net Income After Taxes | -2.49167 | -4.21386 | -1.71527 | -3.84617 | -3.29495 |
| Net Income Before Extra. Items | -2.49167 | -4.21386 | -1.71527 | -3.84617 | -3.29495 |
| Net Income | -2.49167 | -4.21386 | -1.71527 | -3.84617 | -3.29495 |
| Income Available to Common Excl. Extra. Items | -2.49167 | -4.21386 | -1.71527 | -3.84617 | -3.29495 |
| Income Available to Common Incl. Extra. Items | -2.49167 | -4.21386 | -1.71527 | -3.84617 | -3.29495 |
| Diluted Net Income | -2.49167 | -4.21386 | -1.71527 | -3.84617 | -3.29495 |
| Diluted Weighted Average Shares | 28.2513 | 28.0884 | 28.0792 | 27.6454 | 27.5333 |
| Diluted EPS Excluding Extraordinary Items | -0.0882 | -0.15002 | -0.06109 | -0.13913 | -0.11967 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Diluted Normalized EPS | -0.0882 | -0.15002 | -0.06109 | -0.13913 | -0.11967 |
| Other Operating Expenses, Total | 0 | 0 | 0 | ||
| Other, Net | 0.25 | -1.60553 | 1.60553 |
- Annual
- Quarterly
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Total Current Assets | 21.0083 | 29.7815 | 35.6392 | 42.7481 | 49.6158 |
| Cash and Short Term Investments | 20.2603 | 29.0945 | 34.2227 | 41.2028 | 47.6851 |
| Cash & Equivalents | 15.7485 | 20.6371 | 4.82354 | 2.38631 | 5.78635 |
| Short Term Investments | 4.51178 | 8.45745 | 29.3992 | 38.8164 | 41.8988 |
| Total Receivables, Net | 0.37221 | 0.40645 | 1.31244 | 1.11985 | 0.76087 |
| Accounts Receivable - Trade, Net | 0.27783 | 0.2942 | 0.55853 | 0.31874 | 0.27103 |
| Prepaid Expenses | 0.37583 | 0.28056 | 0.10411 | 0.42545 | 1.1698 |
| Other Current Assets, Total | 0 | ||||
| Total Assets | 21.2991 | 30.0724 | 37.4525 | 43.3008 | 50.7442 |
| Long Term Investments | 0.28471 | 0.28471 | 1.51164 | 0 | 0.92265 |
| Other Long Term Assets, Total | 0.00612 | 0.00623 | 0.05131 | 0.05214 | 0.20574 |
| Total Current Liabilities | 2.55572 | 1.62587 | 1.58803 | 0.84964 | 0.7689 |
| Accounts Payable | 0.30906 | 0.52026 | |||
| Accrued Expenses | 0.70956 | 0.48976 | 0.566 | 0.39958 | 0.14796 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 1.84616 | 1.13612 | 1.02202 | 0.141 | 0.10068 |
| Total Liabilities | 2.90866 | 1.62587 | 1.58803 | 0.84964 | 0.7689 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 18.3905 | 28.4466 | 35.8645 | 42.4512 | 49.9753 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
| Common Stock | 0.04048 | 0.03975 | 0.03961 | 0.03897 | 0.03894 |
| Additional Paid-In Capital | 101.026 | 98.0131 | 96.1059 | 94.3852 | 93.9136 |
| Retained Earnings (Accumulated Deficit) | -63.7466 | -50.6763 | -41.3511 | -33.0431 | -27.3514 |
| Treasury Stock - Common | -18.9299 | -18.9299 | -18.9299 | -18.9299 | -16.6259 |
| Other Equity, Total | |||||
| Total Liabilities & Shareholders’ Equity | 21.2991 | 30.0724 | 37.4525 | 43.3008 | 50.7442 |
| Total Common Shares Outstanding | 28.2292 | 27.4942 | 27.3592 | 26.7135 | 28.3278 |
| Note Receivable - Long Term | 0 | 0.25031 | 0.50062 | ||
| Other Liabilities, Total | 0.35294 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Total Current Assets | 16.2413 | 21.0083 | 23.5722 | 26.1564 | 27.9914 |
| Cash and Short Term Investments | 15.4401 | 20.2603 | 22.7478 | 25.6007 | 27.233 |
| Cash & Equivalents | 12.419 | 15.7485 | 13.6606 | 14.0188 | 13.0556 |
| Short Term Investments | 3.02106 | 4.51178 | 9.0872 | 11.5819 | 14.1774 |
| Total Receivables, Net | 0.55705 | 0.37221 | 0.25443 | 0.45475 | 0.54216 |
| Accounts Receivable - Trade, Net | 0.52815 | 0.27783 | 0.17963 | 0.29144 | 0.38496 |
| Prepaid Expenses | 0.24417 | 0.37583 | 0.56997 | 0.10089 | 0.21619 |
| Total Assets | 18.5302 | 21.2991 | 23.8631 | 26.4473 | 28.2822 |
| Long Term Investments | 2.28283 | 0.28471 | 0.28471 | 0.28471 | 0.28471 |
| Other Long Term Assets, Total | 0.0061 | 0.00612 | 0.00614 | 0.00617 | 0.00615 |
| Total Current Liabilities | 1.82648 | 2.55572 | 1.96293 | 3.28849 | 2.59373 |
| Accrued Expenses | 0.53301 | 0.70956 | 0.84245 | 0.5948 | 0.27767 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 1.29347 | 1.84616 | 1.12048 | 2.69368 | 2.31606 |
| Total Liabilities | 2.1353 | 2.90866 | 1.96293 | 3.28849 | 2.59373 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 16.3949 | 18.3905 | 21.9001 | 23.1588 | 25.6885 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.04052 | 0.04048 | 0.04033 | 0.04033 | 0.03981 |
| Additional Paid-In Capital | 101.523 | 101.026 | 100.322 | 99.8658 | 98.5499 |
| Retained Earnings (Accumulated Deficit) | -66.2383 | -63.7466 | -59.5327 | -57.8175 | -53.9713 |
| Treasury Stock - Common | -18.9299 | -18.9299 | -18.9299 | -18.9299 | -18.9299 |
| Total Liabilities & Shareholders’ Equity | 18.5302 | 21.2991 | 23.8631 | 26.4473 | 28.2822 |
| Total Common Shares Outstanding | 28.2642 | 28.2292 | 28.0792 | 28.0792 | 27.5542 |
| Other Liabilities, Total | 0.30882 | 0.35294 |
- Annual
- Quarterly
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -13.0702 | -9.32527 | -8.30797 | -5.69176 | -2.13582 |
| Cash From Operating Activities | -11.2769 | -6.57439 | -5.78289 | -4.40719 | -1.69117 |
| Non-Cash Items | 0.60508 | 1.76081 | 1.39701 | 1.16463 | 1.28542 |
| Cash Taxes Paid | 0 | -0.50062 | -0.50687 | 0 | 0.16374 |
| Cash Interest Paid | |||||
| Changes in Working Capital | 1.18823 | 0.99008 | 1.12806 | 0.11994 | -0.84078 |
| Cash From Investing Activities | 5.22159 | 22.122 | 7.70745 | 3.32832 | -0.81208 |
| Other Investing Cash Flow Items, Total | 5.22159 | 22.122 | 7.70745 | 3.32832 | -0.81208 |
| Cash From Financing Activities | 1.23005 | 0.25547 | 0.55019 | -2.29954 | -6.22253 |
| Financing Cash Flow Items | |||||
| Issuance (Retirement) of Stock, Net | 1.23005 | 0.25547 | 0.55019 | -2.29954 | -6.22253 |
| Issuance (Retirement) of Debt, Net | |||||
| Net Change in Cash | -4.88857 | 15.8135 | 2.43723 | -3.40003 | -8.46787 |
| Foreign Exchange Effects | -0.06326 | 0.01037 | -0.03752 | -0.02162 | 0.25792 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -2.49167 | -13.0702 | -8.85639 | -7.14112 | -3.29495 |
| Cash From Operating Activities | -2.85038 | -11.2769 | -8.64188 | -4.30778 | -1.90651 |
| Non-Cash Items | 0.45699 | 0.60508 | 0.04914 | 1.07275 | 0.51329 |
| Changes in Working Capital | -0.81571 | 1.18823 | 0.16537 | 1.76059 | 0.87514 |
| Cash From Investing Activities | -0.52085 | 5.22159 | 0.72159 | -3.28394 | -5.78394 |
| Other Investing Cash Flow Items, Total | -0.52085 | 5.22159 | 0.72159 | -3.28394 | -5.78394 |
| Cash From Financing Activities | 0.04235 | 1.23005 | 0.98555 | 0.98614 | 0.1158 |
| Issuance (Retirement) of Stock, Net | 0.04235 | 1.23005 | 0.98555 | 0.98614 | 0.1158 |
| Foreign Exchange Effects | -0.00057 | -0.06326 | -0.0417 | -0.01264 | -0.00683 |
| Net Change in Cash | -3.32945 | -4.88857 | -6.97643 | -6.61822 | -7.58149 |
| Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
|---|---|---|---|---|---|---|
| Emalfarb (Mark A) | Individual Investor | 16.3532 | 4670971 | 138478 | 2023-01-03 | |
| Francisco Trust | Corporation | 12.4235 | 3548528 | 0 | 2022-12-31 | LOW |
| Bandera Partners LLC | Investment Advisor/Hedge Fund | 5.4858 | 1566908 | 0 | 2022-12-31 | LOW |
| Chapin Davis Asset Management | Investment Advisor | 2.8695 | 819629 | 819629 | 2022-12-31 | |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.6397 | 753974 | 423 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.885 | 252791 | 815 | 2022-12-31 | LOW |
| Northeast Financial Consultants Inc | Investment Advisor | 0.8753 | 250000 | 0 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7499 | 214208 | 3993 | 2022-12-31 | LOW |
| Tarnok (Michael P) | Individual Investor | 0.6614 | 188929 | 0 | 2022-04-14 | LOW |
| DIM Funds SICAV S.A. | Hedge Fund | 0.4796 | 137000 | 137000 | 2021-12-31 | |
| Sage Mountain Advisors, LLC | Investment Advisor | 0.3731 | 106564 | 0 | 2022-12-31 | MED |
| Herbst (Seth J. M.D.) | Individual Investor | 0.3676 | 105000 | 50000 | 2022-04-14 | MED |
| Rawson (Ping Wang) | Individual Investor | 0.2971 | 84851 | 39351 | 2023-01-03 | LOW |
| Millennium Management LLC | Hedge Fund | 0.2693 | 76910 | -23764 | 2022-12-31 | HIGH |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.2078 | 59355 | 7381 | 2022-12-31 | LOW |
| Hazelton (Joseph P) | Individual Investor | 0.2011 | 57448 | 57448 | 2023-01-03 | |
| Forefront Analytics, LLC | Investment Advisor/Hedge Fund | 0.1999 | 57094 | 16548 | 2022-12-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.198 | 56550 | 0 | 2022-12-31 | LOW |
| Pekin Hardy Strauss Wealth Management | Investment Advisor | 0.172 | 49130 | -2110 | 2022-12-31 | LOW |
| Perkins Capital Management, Inc. | Investment Advisor | 0.1684 | 48100 | 0 | 2022-12-31 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
Leverage
1:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Dyadic International, Inc. Company profile
About Dyadic International, Inc.
Dyadic International, Inc. is a biotechnology platform company. The Company is focused on developing C1 platform for use in human and animal pharmaceutical applications across the world. The C1 platform technology is based on the Myceliopthora thermophila fungus, which the Company named it as C1. The C1 gene expression platform is used in the discovery, development and manufacturing of biologic medicines and vaccines. The C1 technology is a fungal expression system for gene discovery, development, and production of enzymes and other proteins. The C1 technology is commercially available solutions to uptake genes and develop industrial processes to produce volumes of enzymes and other protein products. The Company is also working on COVID-19 related vaccine and antibody opportunities, including COVID-19 vaccine candidate, DYAI-100.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Dyadic International, Inc. revenues increased 66% to $2.1M. Net loss increased 20% to $8.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and Development - Balancing val increase from $2M to $5.8M (expense), General and administration increase of 61% to $3.8M (expense).
Equity composition
Common Stock $.001 Par, 12/10, 100M auth., 31,138,120 issd. insiders own 6.80%.10/29/04, acquired CCP Worldwide Inc. as a reverse acquisition.01/08, Company delisted from AMEX to OTC Pink Sheets.
| Industry: | Biotechnology & Medical Research (NEC) |
140 Intracoastal Pointe Dr Ste 404
JUPITER
FLORIDA 33477
US
Income Statement
- Annual
- Quarterly
News
What is Pi Network?
The Pi Network has 35 million users, despite its crypto still being unavailable on the open market.
12:04, 22 March 2023
Gold price forecast: Is the uptrend for safe-havens set to continue?
Banking crisis and weaker US dollar have been favourable for gold, yet is there more upside potential?
11:40, 22 March 2023
Gold price predictions for next 5 years: Will gold continue rising amid banking fallout?
The yellow metal started 2023 with a bang, yet will it maintain the momentum and for how long?
17:55, 21 March 2023
Cardano price prediction: What is next for ADA?
Can ADA capitalise on a recent price boost?
15:44, 21 March 2023
Nvidia shows off work with AT&T, quantum computing firms at AI conference
Adds details from keynote
15:29, 21 March 2023
ECB tells banks to watch their cash amid turmoil
Adds Enria's comments in parliament
15:27, 21 March 2023
TotalEnergies sticks to 2030 goal for Scope 3 emissions
Adds details, graphic
15:22, 21 March 2023People also watch
Still looking for a broker you can trust?
Join the 500.000+ traders worldwide that chose to trade with Capital.com